…ith filters for RCTs. We restricted our analysis to ipilimumab, nivolumab, pembrolizumab, atezolizumab, avelumab, durvalumab, cemiplimab …
avelumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning avelumab
19 articles · page 2 of 2…nicalTrials.gov between 2014 and 2024 evaluating approved ICIs (nivolumab, pembrolizumab, atezolizumab, durvalumab, avelumab, ipilimumab,…
…arms (n=8,684 patients) with anti-PD-1/PD-L1 agents (nivolumab, pembrolizumab, atezolizumab, avelumab, durvalumab, cemiplimab) for adult soli…
… on peripheral T cell stemness in mice and humans. We show that PDS01ADC treatment in patients with advanced solid tumors boosts periphe…
…s, followed by curative-intent surgery and one year of adjuvant nivolumab. Primary study endpoints included multiomic profiling of surgic…
…sociated with improved clinical response (p=0.0224).Conclusions PDS01ADC treatment increases peripheral NK cells with specific phenotype…
…d.aaf2341Leong JW, Chase JM, Romee R, et al. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity I…